ADPS
LIVE

Serial Number

79353205

Owner

GeneCast Co., Ltd.

Attorney

Max Vern

Filing Date

Aug 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ADPS Trademark

Serial Number: 79353205 • Registration: 7470077

ADPS is a trademark filed by GeneCast Co., Ltd. on August 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GeneCast Co., Ltd. (2 trademarks)

#10006, #10007, #10009 Garden 5 Techno Hall,

Entity Type: 03

Trademark Details

Filing Date

August 12, 2022

Registration Date

August 13, 2024

Published for Opposition

September 26, 2023

Goods & Services

Pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; medical diagnostic test strips for blood analysis; diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; chemical diagnostic reagents for medical use; in vitro diagnostic preparations for medical purposes for detecting cancer; indicators for medical diagnosis, namely, medical diagnostic reagents; reactants for medical diagnosis, namely, medical diagnostic reagents; pharmaceutical preparations for animals and humans for the treatment of cancer; pharmaceutical preparations for diagnosis of cancer; anti-cancer preparations

Wholesale store services featuring medical measuring instruments for cancer diagnosis; retail store services featuring medical measuring instruments for cancer diagnosis; wholesale store services featuring medical instruments; retail store services featuring medical instruments; retail store services featuring diagnostic reagents for medicinal use; retail store services featuring medical diagnostic test strips; wholesale store services featuring medical diagnostic test strips; retail store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring diagnostic reagents for medicinal use; retail store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for animals and humans; retail store services featuring pharmaceutical preparations for animals and humans; retail store services featuring apparatus for clinical diagnosis; wholesale store services featuring apparatus for clinical diagnosis; wholesale store services featuring blood analysis apparatus for diagnosis; retail store services featuring blood analysis apparatus for diagnosis

Apparatus for the treatment of cancer; medical measuring instruments for measuring tumors for cancer diagnosis; medical instruments, namely, biopsy instruments; medical apparatus for detecting cancer; diagnostic measuring apparatus for medical use, namely, medical diagnostic apparatus for analyzing and measuring tumors in the body; apparatus for carrying-out diagnostic tests for testing for cancers for medical purposes; diagnostic apparatus for medical purposes for testing cancers; apparatus for blood analysis for medical use; apparatus for blood monitoring for medical use; medical diagnostic apparatus for detecting cancer for use in the fields of clinical diagnosis; diagnostic, examination, and monitoring equipment in the nature of medical diagnostic apparatus for detecting cancer; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; automatic analyzers for medical diagnosis for analyzing circulating tumor DNA; tools for medical diagnostics in the nature of medical diagnostic apparatus for detecting cancer; medical examination sheets in the nature of medical table sheets for examining tables and operating tables; apparatus for clinical diagnosis; diagnostic apparatus and instruments for medical purposes in the nature of medical diagnostic apparatus for detecting cancer; blood analysis apparatus for medical diagnosis purposes; in vitro diagnostic devices for medical purposes in the nature of medical diagnostic apparatus for detecting cancer

Research and development of technology for biotechnology; biotechnology services, namely, consulting services in the field of biotechnology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; medical research laboratory services; medical research laboratory services for predicting disease; remote monitoring services for medical diagnostic devices; computer programming services for remote data management of medical diagnostic instruments; design of medical diagnostic apparatus and instruments; providing technological support services in the nature of troubleshooting in the nature of diagnosing problems with medical equipment regarding medical diagnostic instruments; providing computer software technical support services in the nature of diagnosing computer hardware and software problems in the field of medical diagnostics; computer programming services for remote control of medical diagnostic systems; engineering services in the medical technology field; blood testing for medical research purposes, not for medical diagnostic purposes; medical research; medical and scientific research, namely, conducting clinical trials for others; blood analysis services; blood analysis services for scientific research purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 1, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jul 5, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Jul 5, 2024 OP.T
OPPOSITION DISMISSED NO. 999999
Jul 5, 2024 OP.D
REFUSAL PROCESSED BY IB
Apr 23, 2024 RFNP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 8, 2024 OPNX
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 27, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Mar 27, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 26, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Mar 26, 2024 OPNC
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 20, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 20, 2024 OPNR
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 25, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 25, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 6, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2023 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 14, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR